Grant
Small molecules to tackle a Big problem: thienopyrimidinones as a new class of integrase allosteric inhibitors to face HIV-1 drug resistance mutations
Small molecules to tackle a Big problem: thienopyrimidinones as a new class of integrase allosteric inhibitors to face HIV-1 drug resistance mutations